Seyed Hossein Shahcheraghi, Maliheh Alimardani, Malihe Lotfi, Marzieh Lotfi, Vladimir N Uversky, Stephanie Tamdem Guetchueng, Sushesh Shrivastsa Palakurthi, Nitin B Charbe, Altijana Hromić-Jahjefendić, Alaa A A Aljabali, Manoj M Gadewar, Sumira Malik, Rohit Goyal, Mohamed El-Tanani, Vijay Mishra, Yachana Mishra, Murtaza M Tambuwala
Glioblastoma, a highly lethal form of brain cancer, is characterized by its aggressive growth and resistance to conventional treatments, often resulting in limited survival. The response to therapy is notably influenced by various patient-specific genetic factors, underscoring the disease's complexity. Despite the utilization of diverse treatment modalities such as surgery, radiation, and chemotherapy, many patients experience local relapse, emphasizing the critical need for improved therapeutic strategies to effectively target these formidable tumors...
April 5, 2024: Pathology, Research and Practice